![](/img/cover-not-exists.png)
PDB24 COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
Hou, X., Wan, X., Li, Y., Ding, Y., Wu, B.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.574
Date:
May, 2019
File:
PDF, 316 KB
english, 2019